Novavax Inc Asset Turnover Ratio (NVAX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novavax inc   (NASDAQ: NVAX)
 

Novavax Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Novavax Inc 's asset turnover ratio, the ratio that measures the ability of Novavax Inc 's assets to generate revenue, sequentially decreased to 0.38 in the second quarter (Jun 30 2026), which does not come as a surprise, as the Novavax Inc continue to experience difficult business climate.

Within sector 18 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 1906 to 2220.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVAX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -27.62 % -18.65 % -16.15 % -25.52 % -19.15 %
Y / Y Revenue Change -76.3 % -79.07 % 66.61 % -16.64 % -42.42 %
Asset Turnover Ratio (TTM) 0.38 0.51 0.91 0.83 0.78
NVAX's Total Ranking # 2220 # 1906 # 796 # 1072 # 1032
Seq. Asset Change -8 % -10.51 % 1.72 % -13.56 % 3.39 %
Seq. Revenue Change -59.36 % -5.18 % 108.87 % -70.55 % -64.11 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 19
Healthcare Sector # 141
Overall Market # 2220

Asset Turnover Ratio Statistics
High Average Low
449.15 23.43 4.24
(Sep 30 2017)   (Dec 31 2023)




NVAX Company Profile • Back to NVAX Efficiency Comparisons • Compare NVAX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Tela Bio Inc   1.18 $ 80.535  Millions$ 68.159  Millions
Liquidia Corporation  1.18 $ 450.907  Millions$ 381.842  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Universal Health Services Inc   1.16 $ 18,114.487  Millions$ 15,622.036  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Puma Biotechnology Inc   1.15 $ 231.244  Millions$ 201.150  Millions
Sunshine Biopharma Inc   1.15 $ 35.347  Millions$ 30.782  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.15 $ 25.185  Millions$ 21.950  Millions
Natera Inc   1.14 $ 2,707.077  Millions$ 2,372.930  Millions
Arbutus Biopharma Corp  1.14 $ 181.720  Millions$ 159.361  Millions
Elite Pharmaceuticals Inc   1.14 $ 140.130  Millions$ 122.899  Millions
Neuronetics Inc   1.14 $ 154.594  Millions$ 135.996  Millions
Mettler toledo International Inc   1.13 $ 4,133.875  Millions$ 3,643.493  Millions
Mimedx Group Inc   1.13 $ 354.086  Millions$ 312.829  Millions
Harvard Bioscience Inc   1.13 $ 88.164  Millions$ 78.072  Millions
Pro dex Inc   1.13 $ 77.548  Millions$ 68.744  Millions
Biodesix Inc   1.12 $ 102.939  Millions$ 91.540  Millions
Cue Biopharma Inc   1.11 $ 37.654  Millions$ 33.860  Millions
Axsome Therapeutics Inc   1.10 $ 776.569  Millions$ 708.527  Millions
Treace Medical Concepts Inc   1.09 $ 205.307  Millions$ 188.082  Millions
Milestone Scientific Inc   1.09 $ 8.855  Millions$ 8.151  Millions
Phibro Animal Health Corporation  1.07 $ 1,516.861  Millions$ 1,423.196  Millions
Tarsus Pharmaceuticals Inc   1.06 $ 606.331  Millions$ 572.249  Millions
Arcutis Biotherapeutics Inc   1.06 $ 463.981  Millions$ 438.122  Millions
Indivior Pharmaceuticals Inc   1.06 $ 1,333.000  Millions$ 1,261.750  Millions
Nrc Health  1.03 $ 139.996  Millions$ 135.327  Millions
Ironwood Pharmaceuticals inc   1.03 $ 389.316  Millions$ 378.164  Millions
Alphatec Holdings Inc   1.03 $ 814.780  Millions$ 792.240  Millions
Eton Pharmaceuticals Inc   1.03 $ 105.279  Millions$ 102.535  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.